Corning Incorporated: Competitive Benchmarking Report

The Business Analysts' Group
August 1, 2014
75 Pages - SKU: BAC6434561
Colby Pharmaceutical Company - Product Pipeline Review - 2014
10/25/2014 | published by: Global Markets Direct
Colby Pharmaceutical Company - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Colby Pharmaceutical Company - Product Pipeline Review - 2014’, provides an overview of the Colby Pharmaceutical Company’s pharmaceutical research and development focus. This report provides  |  read more...
USD 1,500
Clevo Co. (2362) - Financial and Strategic SWOT Analysis Review
10/21/2014 | published by: GlobalData
Clevo Co. (2362) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you  |  read more...
USD 600
Celgene Corp (CELG: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
10/29/2014 | published by: Plunkett Research, Ltd.
Celgene Corp (CELG: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for (Celgene Corp, CELG: NAS) compared  |  read more...
USD 1,795
Circassia Pharmaceuticals plc - Product Pipeline Review - 2014
10/30/2014 | published by: Global Markets Direct
Circassia Pharmaceuticals plc - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Circassia Pharmaceuticals plc - Product Pipeline Review - 2014’, provides an overview of the Circassia Pharmaceuticals plc’s pharmaceutical research and development focus. This report provides  |  read more...
USD 1,500
Cimarex Energy Co (XEC: NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
10/16/2014 | published by: Plunkett Research, Ltd.
Cimarex Energy Co (XEC: NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for (Cimarex Energy Co, XEC: NYS) compared to its  |  read more...
USD 1,795
Campari Milano Spa, Davide in Spirits (World)
10/13/2014 | published by: Euromonitor International
Campari Milano Spa, Davide in Spirits (World) The world leader in liqueurs, Campari continued its strategy of acquisitive expansion in 2014. This profile analyses the company’s efforts to fill gaps in its portfolio, including its move  |  read more...
USD 520
Chindex International Inc (CHDX: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
10/22/2014 | published by: Plunkett Research, Ltd.
Chindex International Inc (CHDX: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for (Chindex International Inc, CHDX: NAS) compared to its  |  read more...
USD 1,795
Community Health Systems Inc (CYH: NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
10/22/2014 | published by: Plunkett Research, Ltd.
Community Health Systems Inc (CYH: NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for (Community Health Systems Inc, CYH: NYS) compared  |  read more...
USD 1,795
CIMAB S.A. - Product Pipeline Review - 2014
10/25/2014 | published by: Global Markets Direct
CIMAB S.A. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘CIMAB S.A. - Product Pipeline Review - 2014’, provides an overview of the CIMAB S.A.’s pharmaceutical research and development focus. This report provides comprehensive information on  |  read more...
USD 1,500
Catabasis Pharmaceuticals, Inc. - Product Pipeline Review - 2014
10/25/2014 | published by: Global Markets Direct
Catabasis Pharmaceuticals, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Catabasis Pharmaceuticals, Inc. - Product Pipeline Review - 2014’, provides an overview of the Catabasis Pharmaceuticals, Inc.’s pharmaceutical research and development focus. This report provides  |  read more...
USD 1,500
 

SELECT A LICENSE

    PDF E-mail From Publisher  USD 1,799  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!